Heart Disease Clinical Trials in Atlanta

Showing 141-160 of 252 trials

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

NCT03308812

This study will recruit from participants in the Morehouse-Emory Cardiovascular (MECA) study for a clinical intervention examining cardiac outcomes between participants who are randomized to received Health360x (a web-based and mobile-based application) or Health360x plus personalized health coaching. Participants will receive instruction on using the Health360x application and will use Health360x alone or Health360x with a health coach for 6 months. Measures of cardiovascular health will be assessed at baseline and after the 6 month long intervention.

Cardiovascular Diseases

Emory University150 participantsStarted Jul 2017

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPHASE3< 1 mile

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

NCT00658515

This study will evaluate the potential of RO4607381 to reduce cardiovascular morbidity and mortality in stable coronary heart disease patients with recent Acute Coronary Syndrome (ACS) and evaluate the long term safety profile of the drug. Eligible patients in stable condition will be randomized to receive either RO4607381 600mg po or placebo po, daily, together with a background of standard medication for ACS (including aspirin, antihypertensives and statins). The anticipated time on study treatment is 2+ years, and the target sample size is 15,600 individuals.

Coronary Heart Disease

Hoffmann-La Roche15,871 participantsStarted Apr 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +1086 more locations

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Heart Disease Trials in Other Cities

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

DF4 Connector System Post-Approval Study

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

HW006 LATERAL Thoracotomy

VITROS Immunodiagnostic Products NT-proBNP II

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Increasing Physical Activity Among Mexican American Women (The Enlace Study)

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

Mitroflow DL Post Approval Study- North America

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Heart Outcomes Prevention and Evaluation 4

e-NOBORI Observational Registry of Nobori DES

Other Conditions in Atlanta